chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the first Pfizer vaccine on 3/16/21 in the afternoon. I am a young, healthy woman with no pre-existing health conditions: I don't smoke, am under 120 lbs., no allergies, etc. Two days after the vaccine, I started to experience an eye twitch, which progressed into Bells Palsy by the following week: by 3/23/2021.   I went to an urgent care clinic and was diagnosed as such, and they contributed to the vaccine and told me not to get the second shot. They also advised I get a CT scan to rule out a stroke, which I did,  on 3/24/21. I expect that they also reported this. I have facial paralysis on the left side of my face, and developed an ear infection a week after this...I don't have allergy issues, and have not had an ear infection since I was a small child. This has been traumatic, uncomfortable and very scary because I thought I was having a stroke.
Information has been received from a physician concerning 3 females who were vaccinated with the first dose of Gardasil (Lot # 656372/0243U). Subsequently the patients experienced metal taste in their mouths five minutes after receiving the vaccine. Medical attention was sought. Additional information has been requested.
FLARED UP ALL OF MY CHRONIC PAIN FOR 2-3 WEEKS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced flared up all of my chronic pain for 2-3 weeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of flared up all of my chronic pain for 2-3 weeks was not reported. This report was non-serious.
On 10/25/2007 my child was given vaccines, which are recommended at 2-month-old age. RotaTeq was the only oral vaccine given. Before 10/25/07 my child had regular stool several times a day. My son is on breast milk only. There were no unusual effects associated with my child's bowl movements. On the next day after the vaccination his stool was reduced to 2 times a day, on the day after to only one time a day, and on the third day there was no stool at all. I contacted a nurse on call at the pediatric care facility off-hours telephone number, and she said that it is OK for a baby not to have stool for up to 10 days because the breast milk gets absorbed so efficiently. She recommended using glycerin suppositories. I waited for 5 days and started using the glycerin. There was a lot of thick mass coming out of my child, which did not look like efficiently absorbed milk. The child passes gas, and there is no change in his behavior other than there is no stool. I use the suppositories for 2 month already, and there is no improvement in the child's bowl movement. He is 4 month old now, and I tried to add some cereal and a vegetable hoping that he starts "going" on his own, but there is no luck. I made an appointment with our doctor, and described what happened. I said that it started right after the vaccination. I asked if it could be a reaction to the RotaTeq vaccine since it was the only oral vaccine, and there were adverse effects recorded in prior years for rotavirus vaccine (RotaShield?) The doctor said there is no connection between the stool problem and the vaccine, and that it is just a coincidence. He said that "babies do that", and prescribed Karo syrup. The doctor refused to refer us to any specialist or to do an additional lab study even after I asked for it. The only study I was referred to was X-ray of esophagus and stomach in relation to possible reflux. I asked doctor if there could be a problem with gallbladder or liver, or maybe anything else. Doctor said, "there is none of that" without doing any studies. I also told the doctor that I did not know what to do, and I tried to give my baby over-the-counter lactobacteria, and it did help - my child had stool just one time on his own. Doctor said that he would not recommend giving my child such medicine. I asked doctor if there could be an infection such as staphylococcus, but the doctor said in such case the baby would have a fever, diarrhea, and pus in his stool. I am not sure if the RotaTeq was the cause of stool problem because there was no study done by the doctor.  I am not sure in what combination the shots I listed were given. When I asked for lot numbers the doctor said they do not have the lot numbers available right away, and I would need to wait a long time to find out. When I asked a nurse to provide manufacturers names or brand names of the vaccines she looked confused and she said that the vaccines are called "rotavirus", "Hepatitis B", "Polio" and so on, and there are no other names for the vaccines. When I asked to look at the bottles and see if there is any other name she got even more confused. I was not able to get either manufacturer or lot number.
Woke up next morning with throbbing arm pain.  Pain got worse over next month moving into anterior chest shoulder blade, elbow and tingling and swelling into hand/fingers.  Has started physical therapy 11/25/2003.  Pain now in upper arm with occasional hand/finger numbness.  Is recovering with physical therapy.
pt presented 7 days post vax & mom noted a red, firm lump in lt thigh but on the day of presentation was able to express purulent drainage;pt remained 2 1/2 x 3cm area of induration;responded to 10 day course of keflex;f/u exam 6DEC w/knot;
Light flu symptoms; Face and head were hot without fever; Blood pressure went up; Itchy rash at the injection site; Rash on back of hands which wasn't itchy; Dull headache; Nausea; Joint pain; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site) and RASH (Rash on back of hands which wasn't itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included METFORMIN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), CHILLS (Chills) and FATIGUE (Tired) had resolved and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sinus congestion, mild headache for 1-2 hours post injection, site sore/warm to touch later same day. Day 2- Took Motrin 4PM for bilateral hip and knee pain & low back achiness. Chills, fell run down, arm sore with occasional twingey pains. Day 3- Tired, foggy, anxious. R arm sore to touch and with movement only. Day 4- Woke up in night  itching random sites-R ankle, L dorsal foot.  Day 5-R shoulder joint achy with arm movement(injection side only) Itchy hive on top of right shoulder, injection site ok.
Patient has A. Fib and on the first dose the EMS was called because of her rapid heart rate. Patient HR became 115 bpm after second dose.  Onsite EMS was called vitals HR 95 BP 175/96. Symtoms subsides and was able to go home.
experienced a seizure after vaccination; This is a spontaneous report from a contactable nurse. A 72-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date as SINGLE for covid-19 immunisation  .  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient experienced a seizure after vaccination on an unspecified date with outcome of unknown.  They took patient to the Emergency Room (ER).  Information on the lot/batch number has been requested.; Sender's Comments: Current information is limited and does not allow a full medical assessment.  Relevant medical history and concomitant drugs are not reported.  Case will be reassessed once receiving additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to agency as appropriate.,Linked Report(s) : US-PFIZER INC-2021610416 Same reporter/drug/event, different patient.
This spontaneous report as received from a nurse refers to a 12 year old female patient. The patient's pertinent medical history and drug reactions/allergies were not reported. The nurse stated that the patient received first dose of GARDASIL (lot #, exp. date, dose, frequency and route were not reported) on 18-AUG-2014, and then she received GARDASIL 9, (lot # L011846 exp. date 16-JUN-2017) 0.5 ml intramuscular on 20-AUG-2015. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
ADMINISTERED HEP B INJECTION WITHOUT AIR BUBBLES. HALF WAY THROUGH INJECTION DONOR STATED INJECTION SHOT WAS HURTING. DONOR HAS WELT ON RIGHT SHOULDER AREA. HARD, SWOLLEN AND WARM TO TOUCH. DONOR STATES ARM HURTS WHEN MOVED. DONOR FEELS TIRED, AND SHAKEY.
PAINFUL SWOLLEN LYMP NODE- FOR THREE TO FOUR DAYS POST VACCINATION. CONTACTED CDC TO BETTER INFORM PATIENT ADVISED TO TAKE ANTI INFLAMATORY NSAID AND USE COOL CLEAN CLOTH TO THE SWOLLEN LYMP NODE UNDER THE ARM
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unspecified gender and age. Information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapy was not provided. On unknown dates, the unspecified number of improperly stored doses of GARDASIL 9 single dose, lo# M013636, expiration date 15-FEB-2018 (route of administration and anatomical location were not reported), were administered to the patients. No adverse effects have been reported. The doses were stored in a temperature of 30 degrees Fahrenheit for 2 hours and 15 minutes. Data logger was involved. There was no previous temperature excursion reported. This is one of several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA005633: US-009507513-1708USA003399.
Experienced an anaphylactic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ANAPHYLACTIC REACTION (Experienced an anaphylactic reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ANAPHYLACTIC REACTION (Experienced an anaphylactic reaction) (seriousness criterion medically significant). At the time of the report, ANAPHYLACTIC REACTION (Experienced an anaphylactic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.  Patient mentioned that he experienced an anaphylactic reaction last year with our Vaccine and wanted an actual list of the ingredients for testing with his HCP.  Patient didn't want to provide any type of information as he "already reported to VAERS".  Company comment:  This case concerns a male patient of an unknown age with no medical history provided, who experienced serious expected event of Anaphylactic reaction after the administration of the mRNA-1273 vaccine (the dose of the vaccine was not specified). The temporal relationship between vaccine administration and the event occurrence cannot be determined as vaccination date and start date of the event were not provided. The outcome of the event was not specified and no details regarding the clinical course of the event were disclosed at the time of this report. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a male patient of an unknown age with no medical history provided, who experienced serious expected event of Anaphylactic reaction after the administration of the mRNA-1273 vaccine (the dose of the vaccine was not specified). The temporal relationship between vaccine administration and the event occurrence cannot be determined as vaccination date and start date of the event were not provided. The outcome of the event was not specified and no details regarding the clinical course of the event were disclosed at the time of this report. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Pt felt feverish on 2-21-19 and when she woke up on 2-22-19, had a temp of 100.3 along with N/V.
Initial information received on 21 August 2009 from a health care professional. A 15 year old female patient with an unknown medical history received MENACTRA in the right deltoid (lot number U2917AA) on 14 August 2009. Illness at the time of vaccination was not reported. On 14 August 2009, 8-10 hours post vaccination, the patient developed diffuse myalgia, fatigue, sweating, and nausea which lasted 36 hours. On 17 August 2009 the patient developed a rash. Recovery status was not provided. No further information provided. Follow up information received on 13 October 2009 from a health care professional. The route of administration MENACTRA vaccine was intramuscular. The patient also received a first intramuscular injection in the left deltoid of GARDASIL (Merck and Co., lot number 00874) and on 14 August 2009. Illness at the time of vaccination was none. Other medications were reported as none. Follow-up information received on 16 November 2009 from a healthcare professional. The patient was seen by a physician on 17 August 2009. No laboratory or diagnostic tests were performed. The patient recovered by 21 August 2009.
Patient was sweating, dizzy and experienced pain on left side of stomach.  911 was called and patient was brought to the hospital.
Admit for COVID. Fully vaccinated. Steroids, Vit-c, Vit-d, O2, zinc, Lovenox. Condition declined and pt was sent home with hospice.
fisrt i felt a lot of mocus after 25 minutes after that i fill pain in my body with weakness in 1 hour, later i felt fever with pain in my body .today i fill pain in my bones with thoat pain and fill weak.
Headache, Myalgia, neck pain, fatigue, redness occurred at bedtime Narrative:  Other Relevant History:
This spontaneous report as received from a nurse refers to multiple patients of unknown ages and genders. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ (lot # N000172, expiry date: 10-JUN-2018) (incorrect product storage) reconstituted with sterile water diluent. The vaccine was stored at a temperature of 0 to 1°C (1.2 C) for 34 minutes. There was no previous temperature excursion. The call was because of the data logger. No adverse effects reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA007422: US-009507513-1708USA007425: US-009507513-1708USA007438: US-009507513-1708USA007198:
Patient complains of headache and fever of 102 first 24 hours after 2nd dose of Moderna vaccine, today developed a head to toe rash /Purpura
Developed a fever of 102.5 with body aches and then 4 days later developed 6 inch patch of redness at the injection site.
Patient received second Moderna vaccine on 4/30 at a pharamcy, and stated next day started to get tachycardia. She stated she has a history of anxiety, so she was not sure if it was from vaccine or not. Patient stated she received the vaccine at a Pharmacy. Unable to obtain lot number.
9*25-07 Vaccine RUE 9-25 thru 10-11 right elbow and wrist pain on ROM only 10-11 when getting out of bed face to floor secondary to ? right or ? left sided weakness no LOC symptoms resolved after walking around no further episode. Injection site - erythema, - edema - fever.
Pfizer vaccine was administered outside of Facility- reported by patient- ? NO LOT NUMBER WERE SUPPLIED --------------------------------------------------------------------------------------------------------------------- I95.9 HYPOTENSION 11/14/2022 ANEMIA I95.9 HYPOTENSION 11/14/2022 DM 2 W NEUROLOGICAL MANIFESTATION I95.9 HYPOTENSION 11/14/2022 NONTRAUMATIC ACUTE KIDNEY INJURY
Arm was almost unmoveable, extremely painful and swollen and red blotches around injection site. Could hardly use arm.
Fever 103.9, chills, muscle and joint pain, headache, no energy. Symptoms eased by May 2, but aches/pain and exhaustion lasted over 5 days.
Adverse event: erythema, previously related lesion on R anterior proximal thigh 6cmx4cm in size. No airway involvement. Treatment: 12.5mg Benadryl q6 hrs, Motrin qHS Disposition: likely full resolution of sx's in 3 days
9/13 11 x7 cm red, warm, oval lesion on ant (L) thigh at site of DTAP booster given on 9/10/10. 9/14 phone report that lesion is resolving.
This literature report concerns a retrospective study, safety and UL (urate-lowering) efficacy of FEB was assessed in 13 successively encountered gout patients (8 men, 5 women; age range, 52 to 85 years) with prior documented severe ALLOPURINOL reactions: SCAR (severe cutaneous ALLO reactions) only, 10 patients; multisystem involvement, 3 patients, including skin (2 patients) acute or acute on chronic renal insufficiency (3), hepatitis (1) and/or hematologic abnormalities (2). All patients had impaired baseline renal function: eCLcr (estimated creatinine clearance) 60-89 ml/min, 4; 30-59 ml/min, 5; 15-29 ml/min, 4. FEB treatment was initiated at 40 mg/day in 12 patients and 20 mg/day in 1. FEB dose was titrated, if permitted by safety and renal function monitoring, to achieve and maintain serum urate levels (sUA) <6.0 mg/dL. All 13 patients were hyperuricemic prior to FEB therapy. One patient (an 85 year old woman), previously hospitalized with documented exfoliative erythroderma during ALLO treatment, developed biopsy-confirmed cutaneous leukocytoclastic vasculitis after 4 days exposure to FEB 40 mg/day. No evidence for other organ system involvement was detected, and the rash resolved promptly after FEB withdrawal. This patient had also received seasonal influenza vaccination (manufacturer unknown) on day 1 of FEB treatment. The event outcome was not reported.
Severe menstrual cramping and start of menstruation and should not have this due to being on birth control. Have had nausea, vomiting, headaches, muscle aches and pains, weakness, insomnia, stomach cramps, loss of appetite, heart palpitations, dizzy spells, near syncopal, loss of energy, and depression. This has all been happing over the course of the last 10 days.
fever up to 103, fine rash, dehydration, pustules back of throat area, dec WBC on ER visit 12MAR97;hosp 13MAR97 IV fluids, ATB IV;
One day after administration of vaccine, patient developed erythema, pain, vesicle at site of innoculation/fever of 102 degrees approximately 48 hrs after admin required treatment with antibiotics.
stopped my Shingles/ Unexpected therapeutic benefit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID:  The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Shingles" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation, reaction(s): "stopped my Shingles"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "stopped my Shingles"; Shingrix (DOSE NUMBER UNKNOWN, SINGLE), for Herpes zoster immunisation, reaction(s): "my shingles were still coming monthly". The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "stopped my Shingles/ Unexpected therapeutic benefit".  Additional information: Patient wanted to share that all COVID 19 shorts and the two booster also stopped Shingles. This third booster did not, patient broke back out a week after 3rd booster. Patient know the Pfizer shots for COVID were not for Shingles but it was an added benefit. Even after patient got shingrix shots, shingles were still coming monthly. So patient guessed the 3rd booster was not as strong.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200068025 same patient, different dose/event;
Two days after receiving vaccine, began with bilateral knee pain and stiffness, shortly followed by rash over both legs. Over the next few hours, the rash became more prominent, and pain in knees, ankle and shins made walking difficult. Went to ER and was diagnosed with  Henoch-Schonlein purpura and told to take Ibuprofen for pain and to follow up with PCP. Rash continued to spread over the next two days to include both upper arms and elbows, with broken blood vessels. Also developed swelling in knees and more severely in ankles.  CBC with differential in ER was reported as normal. Visited PCP 5/23/21, who referred to dermatologist and completed urinalysis which was essentially normal with possible elevated white cells to be cultured.
Had minimal pain at injection site on night of vaccine 12/30/20 and the next day 12/31/20 with no redness or swelling at the site. On 1/1/21 the pain had gone and still had no redness or swelling at the site. Then on 1/7/21 around 1400 I noticed it was itching at the injection site and there was a 1cm area of redness and induration. By 2100 on 1/7/21 the redness and induration had grown to 5-6cm and area was warm. On 1/8/21 by 1500 the redness and induration had grown to 8cm and redness starting to go down the arm. At 1900 the area is still about 8cm and now left axillary lymphadenopathy has developed. I am a NP and am watching it, I will seek treatment tomorrow if no improvement or if it worsens.
Pt recvd 2 doses of Hep B vax on 13NOV90 & 14DEC90 & following the 2nd dose pt exp intermittent twitching in lt eyelid; pt reported that the eye twitching gradually subsided & pt had no further problems; Pt recvd 3rd dose w/no problems;
Patient states that he day after receiving her 1st COVID vaccine she had 2 syncopal episodes and experienced severe dizziness and felt as if her head was "vibrating."
Pt recvd vax approx 3PM @ 6PM pt started to scream for approx 1 hr; Given dose of APAP & taken to Hosp to ER;